Femasys Inc
General ticker "FEMY" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $24.9M
Femasys Inc does not follow the US Stock Market performance with the rate: -0.1%.
Estimated limits based on current volatility of 3.1%: low 1.07$, high 1.13$
Factors to consider:
- US accounted for 90.4% of revenue in the fiscal year ended 2022-12-31
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.60$, 1.61$]
- 2024-12-30 to 2025-12-30 estimated range: [0.62$, 1.63$]
Financial Metrics affecting the FEMY estimates:
- Negative: Non-GAAP EPS, $ of -0.92 <= 0.10
- Negative: Operating profit margin, % of -93.12 <= 1.03
- Negative: Operating cash flow per share per price, % of -44.75 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
Short-term FEMY quotes
Long-term FEMY plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1.18MM | $1.21MM | $1.07MM |
| Operating Expenses | $9.52MM | $12.81MM | $15.58MM |
| Operating Income | $-8.34MM | $-11.60MM | $-14.51MM |
| Non-Operating Income | $0.80MM | $0.21MM | $0.27MM |
| Interest Expense | $0.02MM | $0.01MM | $0.17MM |
| R&D Expense | $4.08MM | $5.81MM | $7.21MM |
| Income(Loss) | $-7.53MM | $-11.39MM | $-14.24MM |
| Taxes | $0.00MM | $0.01MM | $0.00MM |
| Profit(Loss) | $-7.54MM | $-11.39MM | $-14.25MM |
| Stockholders Equity | $26.33MM | $15.24MM | $18.35MM |
| Inventory | $0.21MM | $0.44MM | $0.67MM |
| Assets | $28.58MM | $16.90MM | $27.76MM |
| Operating Cash Flow | $-7.93MM | $-10.73MM | $-11.28MM |
| Capital expenditure | $0.31MM | $0.41MM | $0.14MM |
| Investing Cash Flow | $-0.31MM | $-0.41MM | $-0.14MM |
| Financing Cash Flow | $29.70MM | $-0.68MM | $20.18MM |
| Earnings Per Share* | $-0.64 | $-0.97 | $-0.93 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.